Venclose, a San Jose-based medical device company, just received $27 million in a Series C round led by the Ally Bridge Group. The funding will support the company’s efforts to market its radio ...

SAN JOSE, Calif. – March 19, 2018 – Venclose, Inc., a privately-held Silicon Valley medical technology company, today announced that more than 2,000 patients have been treated with the company’s ...

As described above, the underlying pathologic process behind the formation of varicose veins lies within both deep and superficial reflux. Conventional teaching suggests that the underlying truncal or ...

Sapheon Inc. announced one year data in a 38-patient clinical study of the VenaSeal™ Sapheon® Closure System, an advanced approach to the treatment of saphenous vein disease based on a proprietary ...

MORRISVILLE, N.C.--(BUSINESS WIRE)--Sapheon Inc. announced today that it submitted the first module of the pre-market approval (PMA) application for the VenaSeal® Sapheon Closure System to the U.S.

Please provide your email address to receive an email when new articles are posted on . LAS VEGAS — Treating lateral subdermic venous plexus reflux alleviated symptoms associated with restless leg ...

SANTA ROSA, Calif.--(BUSINESS WIRE)--Sapheon Inc. announced successful enrollment in a 30-patient, prospective, single-arm clinical study of the Sapheon Closure System - a single-use, minimally ...

Chronic venous disease of the lower extremity is a very common condition in the United States. It is estimated that 3% to 8% of the US population has symptomatic lower-extremity venous insufficiency ...

United Vein & Vascular Centers (UVVC), a national leader in minimally invasive vein and vascular care, is pleased to announce the opening of its newest clinic in Inman Park, Georgia. Starting today, ...

LAS VEGAS, Nov. 2, 2025 /PRNewswire/ -- The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine through education and research, today announced results ...

Varicose veins affect nearly half the U.S. adult population. With so many people looking for answers, there are plenty of opinions about how and why vein disease develops and the best treatment ...